[Federal Register Volume 66, Number 7 (Wednesday, January 10, 2001)]
[Notices]
[Pages 1994-1995]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-629]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


The 2001 FDA Science Forum--Science Across the Boundaries

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA), Office of Science is 
announcing the following meeting entitled ``The 2001 FDA Science 
Forum--Science Across the Boundaries.'' The science forum is FDA's key 
scientific meeting that seeks to communicate and promote scientific 
issues relating to scientific development and associated regulatory 
concerns. The 2001 forum is designed to bring FDA scientists together 
with representatives from industry, academia, government agencies, 
consumers groups, international constituents, and the public to explore 
science across the boundaries of these groups.
    Date and Time: The science forum will be held on Thursday, February 
15, 2001, from 8:30 a.m. to 5 p.m., and Friday, February 16, 2001, from 
8:30 a.m. to 4:30 p.m.
    Location: Washington Convention Center, 900 Ninth St. NW., 
Washington, DC 20001.
    Contact: AOAC International, Fulfillment Department, 301-924-7077, 
e-mail: [email protected], or Donna L. Mentch, Food and Drug 
Administration, Office of Science (HF-33), 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-3340, e-mail: [email protected].
    Registration: Attendees may register from 7 a.m. to 5 p.m. on 
February 15, 2001, and from 8 a.m. to 1 p.m. on February 16, 2001. 
Registration and program information are also available at http://www.aoac.org/meetings1/fdascienceforum.html. Attendance will be 
limited; therefore, interested parties are encouraged to register 
early.
    Supplementary Information: Speakers and panelists will address 
emerging issues in privacy and confidentiality, modeling and 
simulation, leveraging and partnerships across FDA boundaries, and 
laboratory accreditation.

[[Page 1995]]

    A poster session featuring all areas of FDA regulatory science will 
be presented to provide an opportunity for interested scientists to 
engage in information exchange with FDA scientists. The session topics 
to be discussed include the following:
    1. Health Informational Privacy: Individual Right or Public Good;
    2. Modeling and Simulation for Transdisciplinary Collaboration: The 
Boeing 777 Story;
    3. Perspectives on Confidentiality, Conflict of Interest, and 
Privacy Issues Surrounding the Advancing Science of Gene Therapy;
    4. Modeling and Simulation Across Pharmaceutical Boundaries;
    5. Privacy and Confidentiality Issues in Registries and in 
Outcomes/Epidemiology Research;
    6. Modeling and Simulation in Clinical Product Development for the 
New Millennium;
    7. Scientific, Privacy, and Ethical Issues Surrounding the 
Advancing Science Genetic Predisposition for Breast Cancer;
    8. Modeling and Simulation: The Path to the Future;
    9. Scientific Training Outside the Boundaries;
    10. Next Generation Leveraging;
    11. Public Health Preparedness for Bioterrorism: Why Leveraging is 
Essential;
    12. Partnering Across the Boundaries;
    13. Global Partnering: Mutual Recognition Agreements and How They 
Affect You.
    The science forum is cosponsored by FDA's Office of Science 
Coordination and Communication, AOAC International, and FDA's Chapter 
of Sigma Xi, The Scientific Research Society.
    If you need special accommodations due to a disability, please 
contact the AOAC International at least 3 weeks in advance.

    Dated: January 4, 2001.
Ann M. Witt,
Acting Associate Commissioner for Policy.
[FR Doc. 01-629 Filed 1-9-01; 8:45 am]
BILLING CODE 4160-01-F